These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial. Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ. Circulation; 1996 Nov 15; 94(10):2389-95. PubMed ID: 8921778 [Abstract] [Full Text] [Related]
3. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL. J Am Coll Cardiol; 1994 Apr 15; 23(5):993-1003. PubMed ID: 8144799 [Abstract] [Full Text] [Related]
8. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N Engl J Med; 1996 Sep 12; 335(11):775-82. PubMed ID: 8778585 [Abstract] [Full Text] [Related]
9. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet; 1999 Feb 06; 353(9151):429-38. PubMed ID: 9989712 [Abstract] [Full Text] [Related]
12. Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis. Martin U, Dörge L, Fischer S. Br J Pharmacol; 1996 May 06; 118(2):271-6. PubMed ID: 8735626 [Abstract] [Full Text] [Related]
13. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina. Rupprecht HJ, Terres W, Ozbek C, Luz M, Jessel A, Hafner G, vom Dahl J, Kromer EP, Prellwitz W, Meyer J. J Am Coll Cardiol; 1995 Dec 06; 26(7):1637-42. PubMed ID: 7594097 [Abstract] [Full Text] [Related]
14. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT. Thromb Haemost; 1997 Oct 06; 78(4):1278-85. PubMed ID: 9364998 [Abstract] [Full Text] [Related]
20. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P. J Am Coll Cardiol; 1993 Oct 15; 22(4):1080-8. PubMed ID: 8409044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]